Oric Pharmaceuticals Inc (ORIC)
EBITDA Growth
-5.11%
TTM · Period ending:
ORIC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.11%period ending
Latest reported-5.11%period ending
ORIC TTM EBITDA YoY % (-74.53% → -5.11%)
Year-over-year change
High-resolution chart · PNG
ORIC ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -5.1079% | |
| -1.7592% | |
| -1.1898% | |
| -12.8464% | |
| -23.9991% | |
| -30.7636% | |
| -27.166% | |
| -28.8575% | |
| -25.4763% | |
| -18.7701% | |
| -18.6192% | |
| -7.2531% | |
| -4.4815% | |
| -0.4251% | |
| -7.9101% | |
| -20.2347% | |
| -27.4384% | |
| -51.4238% | |
| -61.9898% | |
| -77.0097% | |
| -88.5836% | |
| -85.5285% | |
| -74.5253% |